GE HealthCare, Mayo Clinic collaborate to advance innovation in medical imaging, theranostics

Building upon a long history of research collaborations between the two organizations, the alliance will deepen the collaborative efforts by focusing on four core areas:

1. Rapidly accelerating the development and clinical translation of advanced Magnetic Resonance (MR) technologies and techniques, transforming patient care through artificial intelligence (AI) enabled exams from order to report.
2. Transforming cancer care through precise imaging and dosimetry of highly targeted theranostic agents and enabling broader access through more efficient radioisotope production.
3. Making diagnostic and interventional ultrasound easier and faster to use and read, while advancing automation and quantification to improve patient access, consistency of care and clinician experience.
4. Improving the patient imaging experience across the care continuum by leveraging multi-modal data, AI and digital health platforms that together streamline clinical operations and support more personalized diagnosis and therapy.

“Mayo Clinic is globally acknowledged to be among the best in healthcare and care innovation. By collaborating with their scientists, inventors and healthcare providers, we will accelerate innovation and increase the clinical impact of our technologies beyond what either of our organizations could achieve independently,” says Jan Makela, president and CEO of Imaging, GE HealthCare.

The multi-focal collaboration brings together clinical research, product development, application of new clinical uses and techniques, and increased access for patients. It features close alignment between research teams and the medical departments that depend on radiological data, spanning multiple radiological disciplines, cardiology, oncology, radiation oncology, vascular, neurology, nuclear medicine and urology. Collaboration activities and research will take place at Mayo Clinic’s campus in Rochester, Minnesota.